|
|
|
Volumn 96, Issue 5, 1997, Pages 1370-1373
|
|
HMG-CoA reductase inhibitors reduce transplant coronary artery disease and mortality: Evidence for antigen-independent mechanisms?
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CALCIUM CHANNEL BLOCKING AGENT;
CHOLESTEROL;
CYCLOSPORIN;
HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;
INSULIN;
LOW DENSITY LIPOPROTEIN;
MEVINOLIN;
NICOTINIC ACID;
PRAVASTATIN;
SIMVASTATIN;
TRIACYLGLYCEROL;
VERY LOW DENSITY LIPOPROTEIN;
ALLOIMMUNITY;
ANGIOCARDIOGRAPHY;
ARTERY INTIMA PROLIFERATION;
CHOLESTEROL BLOOD LEVEL;
CORONARY ARTERY ATHEROSCLEROSIS;
CORONARY ARTERY DISEASE;
DIET;
EDITORIAL;
GENETIC PREDISPOSITION;
GRAFT FAILURE;
HEART INFARCTION;
HEART TRANSPLANTATION;
HYPERLIPIDEMIA;
INSULIN RESISTANCE;
LIPOPROTEIN BLOOD LEVEL;
MORTALITY;
OBESITY;
PRIORITY JOURNAL;
RISK FACTOR;
SUDDEN DEATH;
TRIACYLGLYCEROL BLOOD LEVEL;
ANTIGENS;
CORONARY DISEASE;
ENZYME INHIBITORS;
HEART TRANSPLANTATION;
HUMANS;
HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS;
POSTOPERATIVE COMPLICATIONS;
|
|
EID: 0030876310
PISSN: 00097322
EISSN: None
Source Type: Journal
DOI: None Document Type: Editorial |
|
Times cited : (21)
|
|
References (22)
|
